Search Results - "Bussler, Holm"
-
1
SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
Published in Neurobiology of disease (2015)“…Abstract Multiple sclerosis (MS) is a chronic neuroinflammatory disease characterized by immune cell infiltration of CNS, blood–brain barrier (BBB) breakdown,…”
Get full text
Journal Article -
2
CXCL13 antibody for the treatment of autoimmune disorders
Published in BMC immunology (12-02-2015)“…Homeostatic B Cell-Attracting chemokine 1 (BCA-1) otherwise known as CXCL13 is constitutively expressed in secondary lymphoid organs by follicular dendritic…”
Get full text
Journal Article -
3
Use of poxvirus display to select antibodies specific for complex membrane antigens
Published in mAbs (31-12-2023)“…Antibody discovery against complex antigens is limited by the availability of a reproducible pure source of concentrated properly folded antigen. We have…”
Get full text
Journal Article -
4
Generation and preclinical characterization of an antibody specific for SEMA4D
Published in mAbs (01-01-2016)“…Semaphorin 4D (SEMA4D or CD100) is a member of the semaphorin family of proteins and an important mediator of the movement and differentiation of multiple cell…”
Get full text
Journal Article -
5
Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
Published in Journal for immunotherapy of cancer (04-11-2015)“…Semaphorin 4D (SEMA4D, CD100) and its receptor plexin-B1 are broadly expressed in cancer and expression correlates with invasive disease in several human…”
Get full text
Journal Article -
6
Mouse strain specificity of the IgE response to the major allergens of Phleum pratense
Published in International Archives of Allergy and Immunology (01-04-2005)“…IgE immune responses against major allergens from Phleum pratense in low- and high-responder mouse strains were compared and the influence of alum was…”
Get full text
Journal Article -
7
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
Published in Cancer immunology research (01-06-2015)“…Semaphorin 4D (SEMA4D, CD100) and its receptor plexin-B1 (PLXNB1) are broadly expressed in murine and human tumors, and their expression has been shown to…”
Get more information
Journal Article -
8
Abstract 1545: Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Anti-semaphorin 4D (SEMA4D, CD100) blocking antibody promotes immune infiltration, reduces immunosuppressive myeloid cells, and enhances T cell activity and…”
Get full text
Journal Article -
9
Abstract B199: Targeting the tumor microenvironment with first-in-class Semaphorin4D MAb for combination immunotherapy
Published in Molecular cancer therapeutics (01-01-2018)“…Purpose: Mechanistic findings in preclinical studies demonstrate that antibody blockade of Semaphorin 4D (SEMA4D, CD100) reduces expansion of MDSC and shifts…”
Get full text
Journal Article -
10
Abstract 3661: Breaking down the barrier restricting infiltration and differentiation of APC in the tumor microenvironment with a first-in-class antibody targeting Semaphorin4D, and rational combination therapies
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Purpose: We expand mechanistic findings in preclinical studies to demonstrate that antibody blockade of Semaphorin 4D (SEMA4D, CD100) reduces expansion of MDSC…”
Get full text
Journal Article -
11
Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Purpose: In preclinical models, tumor growth inhibition by anti-semaphorin 4D (SEMA4D, CD100) blocking antibody is enhanced when combined with various…”
Get full text
Journal Article -
12
Abstract 4888: Antibody blockade of semaphorin 4D breaks down stromal barriers to enhance tumoricidal immune infiltration, supporting rational immunotherapy combinations
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Semaphorin 4D (SEMA4D, CD100) and its receptor plexin-B1 are broadly expressed in cancer; increased expression correlates with poor prognosis. SEMA4D normally…”
Get full text
Journal Article -
13
Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and inhibits tumor growth. (TUM7P.1030)
Published in The Journal of immunology (1950) (01-05-2015)“…Semaphorin 4D (SEMA4D, CD100) and its receptor plexin-B1 are broadly expressed in cancer and expression correlates with invasive disease. A novel function of…”
Get full text
Journal Article -
14
Development of anti-CXCL13 monoclonal antibody for the treatment of autoimmune and immuno-oncological disorders (THER2P.950)
Published in The Journal of immunology (1950) (01-05-2015)“…The chemokine CXCL13 is expressed in secondary lymphoid organs by follicular dendritic cells and macrophages and is also expressed by TH17 cells. It is the…”
Get full text
Journal Article -
15
Abstract 278: Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and reverses tumor growth
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Semaphorin 4D (SEMA4D, CD100) and its receptor plexin-B1 are broadly expressed in cancer and expression correlates with invasive disease in several human…”
Get full text
Journal Article -
16
Abstract 5030: Antibody blockade of Semaphorin 4D promotes tumor rejection and improves response to immune checkpoint blockade and chemotherapy
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Semaphorin4D (SEMA4D) normally functions to regulate, adhesion, motility and activation state of multiple cell types including those of the nervous, vascular…”
Get full text
Journal Article -
17
Abstract 1245: Reduction of tumor growth and metastasis by a humanized IgG4 monoclonal antibody to SEMA4D (VX15/2503)
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Semaphorin 4D (SEMA4D; CD100) has been implicated in several key mechanisms of tumor progression, including transactivation of several oncogenes, metastasis,…”
Get full text
Journal Article -
18
Antibody-mediated neutralization of Sema4D reduces tumor angiogenesis and growth in vivo
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
19
Abstract 2531: Reduction of In Vivo Tumor Growth and Angiogenesis by a Humanized IgG4 Monoclonal Antibody to SEMA4D
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Semaphorin 4D (SEMA4D; CD100) has been implicated in several key mechanisms of tumor progression, including metastasis, tumor invasion, and neovascularization…”
Get full text
Journal Article -
20
Abstract 3667: Reduction of in vivo tumor growth and angiogenesis by a humanized IgG4 monoclonal antibody to SEMA4D
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Semaphorin 4D (SEMA4D; CD100) has been implicated in several key mechanisms of tumor progression, including neovascularization, tumor invasion, and metastasis…”
Get full text
Journal Article